Literature Review of Recombinant Tissue Plasminogen Activator Used for Recent-Onset Submacular Hemorrhage Displacement in Age-Related Macular Degeneration

Compatibility of Recombinant Tissue Plasminogen Activator and Bevacizumab Co-Applied for Neovascular Age-Related Macular Degeneration With Submacular Hemorrhage

(2012) Alexa Klettner et al.   ARCHIVES OF OPHTHALMOLOGY

The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha

(2011) K. van Bilsen et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage

(2011) Felix Treumer et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator

(2011) Takeshi Mizutani et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

VITREOUS HEMORRHAGE COMPLICATING INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR AND PNEUMATIC DISPLACEMENT OF SUBMACULAR HEMORRHAGE

(2011) Tsung-Tien Wu et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Intravitreal Tissue Plasminogen Activator and Pneumatic Displacement of Submacular Hemorrhage

(2010) Ya-Hsin Kung et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Kombinierte intravitreale Injektion von rTPA, Gas und Ranibizumab zur Behandlung großflächiger subfovealer Blutungen bei neovaskulärer altersbedingter Makuladegeneration

(2010) G. Matt et al.   KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

SURGICAL OUTCOMES AFTER MASSIVE SUBRETINAL HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION

(2010) Howard F Fine et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

EPIDEMIOLOGY OF THE ASSOCIATION BETWEEN ANTICOAGULANTS AND INTRAOCULAR HEMORRHAGE IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

(2010) Daniel F Kiernan et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

INTRAVITREOUS INJECTION OF BEVACIZUMAB, TISSUE PLASMINOGEN ACTIVATOR, AND GAS IN THE TREATMENT OF SUBMACULAR HEMORRHAGE IN AGE-RELATED MACULAR DEGENERATION

(2010) Rainer Guthoff et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage

(2009) F Treumer et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator

(2009) Jost Hillenkamp et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

A 40° GAZE DOWN POSITION FOR PNEUMATIC DISPLACEMENT OF SUBMACULAR HEMORRHAGE

(2009) HARVEY LINCOFF et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

BEVACIZUMAB (AVASTIN) DOES NOT HARM RETINAL FUNCTION AFTER INTRAVITREAL INJECTION AS SHOWN BY ELECTRORETINOGRAPHY IN ADULT MICE

(2009) PETER HEIDUSCHKA et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

EFFECTS OF INTRAVITREAL BEVACIZUMAB IN REPEATED DOSES

(2009) AYCA SARI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study

(2008) Carsten H. Meyer et al.   ACTA OPHTHALMOLOGICA

Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration

(2008) S Sacu et al.   EYE

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY